Investor · Raleigh, NC

Clayton Duncan

Open Clayton in the network graph →

Filings

5

SEC Form D

Connections

24

co-filers

Capital

$421K

across filings

Active

Aug 2012

to Jan 2020

Most-connected co-filers (24)

Scott Singleton · HOUSTON, TX2 shared Grady P. Appleton · Columbus, OH1 shared Dennis S. Guest · Columbus, OH1 shared Jeanne P. Golliher · Columbus, OH1 shared Scott A. Meacham · Oklahoma City, OK1 shared Moise Khayrallah · Durham, NC1 shared Ravi Inukonda · WILMINGTON, DE1 shared Lauris Lietavietis · WILMINGTON, DE1 shared Artis Kehris · WILMINGTON, DE1 shared Dino Becirovic · WILMINGTON, DE1 shared Janis Berdigans · WILMINGTON, DE1 shared Catherine S. Cawthon · COLUMBUS, OH1 shared Eric Toone · Boston, MA1 shared Sam Hopkins · Raleigh, NC1 shared Pei J. Zhou · Raleigh, NC1 shared Carl Edwards · Atlantic Beach, FL1 shared Richard E. Gammans · Oklahoma City, OK1 shared Mark I. Corrigan · Oklahoma City, OK1 shared Bennett W. Love · Oklahoma City, OK1 shared Accele Venture Advisors I, LLC · Oklahoma City, OK1 shared Stephen Prescott · Oklahoma City, OK1 shared Richard W. Reichow · Chapel Hill, NC1 shared Harold D. Keller · Columbus, OH1 shared W B. Love · Chapel Hill, NC1 shared

Recent filings (5)

Valanbio Therapeutics, Inc.Jan 2020 · 14 co-filers$600K Synereca Pharmaceuticals, Inc.Aug 2017 · 6 co-filers$1.2M Synereca Pharmaceuticals, Inc.Aug 2017 · 6 co-filers$1.2M Accele BioPharma, Inc.Sep 2012 · 4 co-filers$2.6M Accele BioPharma, Inc.Sep 2012 · 4 co-filers$2.6M Accele Venture Partners I, LPAug 2012 · 2 co-filers$20.0M Accele Venture Partners I, LPAug 2012 · 2 co-filers$20.0M Synereca Pharmaceuticals, Inc.Feb 2011 · 5 co-filers$340K Synereca Pharmaceuticals, Inc.Feb 2011 · 5 co-filers$340K

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Clayton in the interactive graph →